Zogenix Inc (ZGNX): ZGNX stock is up 15.98% today ... Article printed from InvestorPlace Media, http://investorplace.com/2016/03/biggest-movers-in-manufacturing-stocks-now-zyne-flks-zgnx-epzm/.
Zogenix, Inc. ZGNX, a pharmaceutical company which is committed to developing and commercializing therapies for central nervous system disorders, could be an interesting play for investors. That is because, not only does the stock
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZGNX at https://www.zacks.com/ap/ZGNX Keywords: Zogenix, Earnings …
Zogenix (ZGNX) stock has experienced severe weakness over the last three months dropping 65%. Effort by Massachusetts Governor to ban recently launched drug, Zohydro, has created uncertainty. Imminent ruling by District …
In addition to the $35 million acquisition cost in cash and Zogenix stock (11,995,202 shares to be registered), the terms of the purchase agreement includes $50 million in potential regulatory milestone payments and up to $45 million in royalty …
ZGNX) announced an agreement for the sale of its Zohydro ER (hydrocodone bitartrate) business to Pernix for $100 million. This transaction will be composed of $30 million in cash, $20 million in Pernix common stock and a $50 million short …
including a minimum of $30 million in cash and $20 million in PTX common stock (based on the closing price on March 9, 2015). Under the agreement, Pernix will issue to Zogenix a 6 month $50 million promissory note which accrues …
Tribune Publishing Company Comm (TPUB): TPUB stock is up 14.37% today. Zogenix Inc (ZGNX): ZGNX stock is up 13.16% today. Anthera Pharmaceuticals (ANTH): ANTH stock is up 12.5% today. Vital Therapies Inc (VTL): VTL stock
Zogenix Inc. (NASDAQ: ZGNX) has been a controversial small cap drug stock, with its abuse-deterrent Zohydro being at front and center. Now that the company has submitted its supplemental new drug application (sNDA) with the U.S. …
GW Pharmaceuticals (NASDAQ: GWPH) used to be a high-flying marijuana stock. The cannabinoid-focused biotech captured ... Probably the biggest worry of all, though, comes from the threat of competition. Zogenix (NASDAQ: …